Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Patients' follow-up.
| Whole cohort | ||
|---|---|---|
| N = 99(%) | ||
| ICI regimens | Pembrolizumab | 71 (72%) |
| Nivolumab | 7 (7%) | |
| Atezolizumab | 8 (8%) | |
| Durvalumab | 11 (11%) | |
| Other | 2 (2%) | |
| Single agent or combined | Monotherapy | 33 (33%) |
| Combinaison | 66 (67%) | |
| Line of treatment | 1st line | 60 (61%) |
| 2nd line | 33 (33%) | |
| ≥3rd line | 6 (6%) | |
| Myocarditis | 3 (3%) | |
| Follow-up | Median follow-up (days) | 209 [147; 249] |
| Mortality rate | 28 (28%) |
ICI, Immune checkpoint inhibitors.
